Average Co-Inventor Count = 6.82
ph-index = 2
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Genentech, Inc. (14 from 3,222 patents)
2. University of California (5 from 15,475 patents)
3. F. Hoffmann-la Roche Ag (168 patents)
19 patents:
1. 12234245 - Sulfonimidamide compounds as inhibitors of interleukin-1 activity
2. 12202824 - Oxadiazole transient receptor potential channel inhibitors
3. 11655245 - Oxadiazole transient receptor potential channel inhibitors
4. 11560391 - Sulfonylurea compounds as inhibitors of interleukin-1 activity
5. 10913742 - Oxadiazolones as transient receptor potential channel inhibitors
6. 10766878 - Sulfonylcycloalkyl carboxamide compounds
7. 10711004 - Oxadiazole transient receptor potential channel inhibitors
8. 10710994 - Oxadiazole transient receptor potential channel inhibitors
9. 10695348 - Sulfonyl pyridyl TRP inhibitors
10. 10647731 - Thiazolopyrimidinones and methods of use thereof
11. 10597383 - Bicyclic proline compounds
12. 10280165 - Pyridopyrimidinones and methods of use thereof
13. 10179782 - Substituted sulfonamide compounds
14. 9988400 - Thiazolopyrimidinones and methods of use thereof
15. 9629911 - Photoreactive regulator of protein function and methods of use thereof